Heron Therapeutics Inc (HRTX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché HRTX Giù? Forum Previsione Frazionamento azionario

Heron Therapeutics Inc Azioni (HRTX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	6.22% 40.59	38.21	37.20	38.90	40.78
Cost Of Revenue	6.67% 11.12	11.91	9.857	8.457	10.23
Gross Profit	12.05% 29.47	26.30	27.34	30.45	30.55
Operating Expenses	3.16% 29.43	30.39	28.98	27.29	26.38
Benefits Costs and Expenses	43.27% 43.54	30.39	28.98	27.29	26.38
Costs And Expenses	3.16% 29.43	30.39	28.98	27.29	26.38
Operating Income/Loss	100.93% 0.038	-4.093	-1.637	3.154	4.173
Income/Loss From Continuing Operations Before Tax	137.77% -2.954	7.821	-2.381	2.635	14.40
Income/Loss From Continuing Operations After Tax	83.12% -2.954	-17.50	-2.381	2.635	3.663
Net Income/Loss	83.12% -2.954	-17.50	-2.381	2.635	3.663
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	95.78% 7.183	170.35	154.02	153.49	0.236
Diluted Average Shares	95.78% 7.183	170.35	154.02	196.92	0.236
Basic Earnings Per Share	90.00% -0.010	-0.10	-0.02	0.02	0.02
Diluted Earnings Per Share	90.00% -0.010	-0.10	-0.02	0.01	0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$27.36

1.82%

RPRX

$47.03

3.20%

MRNA

$53.54

4.29%

BNTX

$88.77

2.26%

ONC

$283.45

2.81%

INSM

$148.31

6.59%